Searchable abstracts of presentations at key conferences in endocrinology

ea0016p481 | Neuroendocrinology | ECE2008

Hypopituitarism after traumatic brain injury and its possible relation with neurocognitive and psychiatric disturbances

Castro Ana I , Lage Mary , Peino Roberto , Lorenzo Monica , Casanueva Felipe

Introduction: Recent advances in medicine have allowed a considerably decrease in mortality after traumatic brain injury (TBI) with the consequent increment in the number of subjects with physical, psychological and cognitive sequelas which means an important worsening of quality of life as well as difficulties in social and labour integration. Considering that many of the symptoms classically attributed to the TBI (memory impairment, concentration impairment, fatigue, social ...

ea0081ep904 | Reproductive and Developmental Endocrinology | ECE2022

Development of ANA antibodies induced by estrogen treatment.

Medina Rivero Daniel , Gavira Isabel Mateo , Larran Escandon Laura

A 36-year-old woman in follow-up due to early ovarian failure of idiopathic origin. No family history of interest. History of menarche at 12 years of age with regular menses until 18 years of age, when it begins with amenorrheic spells lasting up to 8 months. Laboratory tests revealed hypergonadotropic hypogonadism with negative ovarian autoantibodies, normal karyotype, and gynecological ultrasound showing a normal-looking uterus with slight bilateral ovarian atrophy. Negative...

ea0037oc7.5 | Neuroendocrinology and pituitary-basic | ECE2015

Not so giants: mice lacking both somatostatin and cortistatin have high GH levels, but show no changes in growth rate or IGF-I levels

Luque Raul M , Gahete Manuel D , Pedraza-Arevalo Sergio , Pozo-Salas Ana I , L-Lopez Fernando , de Lecea Luis , Cordoba-Chacon Jose , Castano Justo P

Somatostatin (SST) and cortistatin (CORT) are two highly related neuropeptides involved in the regulation of several endocrine secretions. In particular, SST and CORT are two primary negative regulators of GH secretion. Consequently, SST or CORT knockout (KO) mice exhibit elevated GH levels; however, this does not lead to increased IGF-I levels or somatic growth, which has been suggested that could be due to a compensatory mechanism between both peptides. In order to test this...

ea0037ep1337 | Clinical Cases–Thyroid/Other | ECE2015

Recurrent severe symptomatic hyponatraemia induced by low-dose oral cyclophosphamide in a patient with ANA-related vasculitis

Dineen Rosemary , Pazderska Agnieszka , Mullan Ronan , Gibney James , Sherlock Mark

Cyclophosphamide is an alkylating agent used in the treatment of malignant and autoimmune diseases. Severe hyponatraemia is a serious electrolyte disorder with life threatening neurological sequelae. We report a case of recurrent severe, symptomatic hyponatraemia that developed in a 61 year old female with systemic vasculitis and Sjogrens syndrome following low-dose cyclophosphamide.Case report: A 61 year old lady, with ANA positive systemic vasculitis p...

ea0005p151 | Endocrine Tumours and Neoplasia | BES2003

IGF-I inhibits COX-2 function in primary colonic biopsies of patients with acromegaly

Kelly P , Vojnovic I , Fairclough P , Warner T , Bustin S , Jenkins P

Introduction: Cyclooxygenase-2 (COX-2), an inducible enzyme in prostaglandin synthesis, plays a major role in the pathogenesis of sporadic colorectal carcinoma (CRC). COX-2 inhibitors reduce the mortality from sporadic CRC. Acromegaly is associated with an increased risk of CRC, with a preponderance of right sided disease, but COX-2 protein is reduced or absent in acromegalic normal and malignant colonic mucosa. The mechanisms responsible for this are unknown.Aims: (i) To ...

ea0041ep562 | Diabetes therapy | ECE2016

Insulin pump therapy-a different solution for treating diabetes type I

Pejaković Sladana , Tešić Dragan , Stokić Edita , Milankov Andrijana , Prodanović Jovana , Perčić Ivanka , Mitrović Milena , Kovačev-Zavišić Branka

Introduction and aim: Continuous subcutaneous insulin infusion via insulin pump is the most efficient way of imitating physiological insulin secretion, and it also provides better management of diabetes, lower rate of hypoglicemic episodes, better quality of life and prevention of long-term complications of diabetes mellitus. Aim of the research was to determine effects of subcutaneous insulin infusion therapy on parameters of glycoregulation during the two years trial.<p ...

ea0019p197 | Growth and development | SFEBES2009

Altered IGF-I signalling in children born small for gestational age without catch up growth

Butcher I , Whatmore A , Murray P , Westwood M , Clayton P

Background: Infants born small for gestational age (SGA) usually show catch-up growth during the first few years of post-natal life. However, some infants remain small and little is known about the factors governing their growth failure. IGF-I receptor mutations account for a minority of cases therefore we have initiated an assessment of signalling molecules downstream of the receptor.Method: Skin biopsies were obtained with local ethics approval from he...

ea0041ep616 | Endocrine tumours and neoplasia | ECE2016

Clinical benefit of patients with advanced adrenocortical carcinoma (Acc) treated in phase I clinical trials: the royal marsden hospital (Rmh) experience

Custodio Ana , Lopez Juanita , de Bono Johann S

Introduction: After progression on conventional treatment options, some patients with advanced ACC are offered experimental Phase I therapies. The outcomes of these patients have not yet been formally evaluated. This study aims to describe the experience of refractory ACC patients treated on Phase I clinical trials at the RMH.Methods: We retrospectively reviewed the records of metastatic ACC patients consecutively treated in our Drug Development Unit bet...

ea0032p752 | Obesity | ECE2013

Monocyte chemoattractant protein-1 is associated with apolipoprotein A-I and apolipoprotein e levels in obese premenopausal women

Silva-Nunes Jose , Peeraly Zulmira , Pedroso Nuno , Oliveira Ana , Duarte Leone , Brito Miguel , Veiga Luisa

Background: Obesity represents a cardiovascular risk factor. Monocyte chemoattractant protein-1 (MCP-1) is a known regulator of monocyte recruitment to sites of inflammation, and participates at the early phases of atherogenesis. Apolipoproteins, as part of the lipoprotein particles, are classically coupled with cardiovascular risk distinction.Aims: To assess the association of anthropometric parameters, insulin resistance and MCP-1 levels with classic l...

ea0049ep1204 | Clinical case reports - Thyroid/Others | ECE2017

Isolated ocular Miasthenia Gravis and Graves’ disease – a challenging ophtalmopathy

de Castro Raquel Vaz , Aragues Jose Maria , Ferreira Florbela , Gomes Vania , Wessling Ana , Fonseca Ana Claudia , Conceicao Isabel , Bugalho Maria Joao

We report the case of a Caucasian woman presenting with a challenging differential diagnosis of ophtalmopathy. The patient was diagnosed with GravesÂ’ disease during postpartum at the age of 28 (TSH<0.001 U/ml; FT3 6.7 ng/dl; FT4 2.2 ng/dl; TSAb 15 U/l). Besides 16 pack-year smoking history, no other previous disease was known. At examination, exophthalmos grade I/III with bilateral lid retraction was evident. Persistency of the disease despite optimal use of medical a...